Tesamorelin
Growth Hormone Releasing Peptide - GHRH analog studied for growth-hormone-axis research.
Tesamorelin is a synthetic 44-residue analog of growth-hormone-releasing hormone, stabilised against enzymatic degradation. It is characterised in the literature for binding at the GHRH receptor and the pulsatile growth-hormone secretion observed in endocrine research models.
Tesamorelin is a stabilised GHRH(1-44) analog and one of the better-characterised growth-hormone-axis compounds in the catalogue. Research interest centres on GHRH-receptor binding and the pulsatile growth-hormone secretion it produces in endocrine research models.
Tesamorelin specifications
- Sequence
- Stabilised GHRH(1-44) analog
- Presentation
- Lyophilised powder
- Documented purity
- 99.70% by HPLC
- Available sizes
- 10mg ($105)
- Archived COA lots
- 4
- Intended use
- Laboratory research use only. Not for human or veterinary use.
Studied pathways
- GHRH receptor - Stabilised GHRH analog studied for pulsatile growth-hormone release.
Reported mechanisms in the literature
- GHRH receptor - A stabilised analog of growth-hormone-releasing hormone, characterised for GHRH-receptor binding and pulsatile GH secretion in endocrine research models. (Falutz et al.)
Tesamorelin frequently asked questions
What is Tesamorelin?
A synthetic 44-residue analog of growth-hormone-releasing hormone, characterised for GHRH-receptor binding and endogenous GH secretion in endocrine research models.
Is Tesamorelin approved?
Not for any use offered here. The material supplied by Aspect Peptides is a research chemical, not a medicine, and is provided strictly as a reference standard for in-vitro laboratory research.
What is it researched for?
GHRH-receptor pharmacology and growth-hormone-axis signalling in endocrine research models.
Documented to 99.70% purity by HPLC · third-party COA every lot · from $105 · For laboratory research use only.
Related Growth Hormone compounds
- Ipamorelin - Selective GH secretagogue studied for receptor-selective GH release.
- CJC-1295 - GHRH analog studied for sustained GH signalling.
- CJC-1295 DAC - Long-acting GHRH analog with drug-affinity complex.